NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE68355 Query DataSets for GSE68355
Status Public on May 22, 2015
Title ChIP-seq of ER, PR, p300 in two ER+ breast cancer cell lines treated with estrogen and with and without progestins
Organism Homo sapiens
Experiment type Genome binding/occupancy profiling by high throughput sequencing
Summary Exploring effect of progesterone/progestin treatment on ER and PR binding.
 
Overall design Two cell lines, three conditions (Full Media with E2, E2+ Progesterone, Full Media + R5020 Progestin), three factors (ER, PR, p300), all with three replicates, each with a matched Input control.
 
Contributor(s) Mohammed H, Stark R
Citation(s) 26153859
Submission date Apr 28, 2015
Last update date May 15, 2019
Contact name Chandra Chilamakuri
E-mail(s) datasubmissions@cruk.cam.ac.uk
Organization name Cancer Research UK Cambridge Institute
Street address Robinson Way
City Cambridge
ZIP/Postal code CB2 0RE
Country United Kingdom
 
Platforms (1)
GPL11154 Illumina HiSeq 2000 (Homo sapiens)
Samples (67)
GSM1669011 JC1553_T47D_ER_Full_Media_3hr r1
GSM1669012 JC1563_T47D_ER_Full_Media_3hr r2
GSM1669013 JC1573_T47D_ER_Full_Media_3hr r3
This SubSeries is part of SuperSeries:
GSE68359 Progesterone receptor directs a distinct estrogen receptor-alpha chromatin binding profile in breast cancer to elicit good clinical outcome
Relations
BioProject PRJNA282508
SRA SRP057755

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE68355_RAW.tar 38.6 Mb (http)(custom) TAR (of TXT)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file
| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap